Rubius Therapeutics, Inc. Debt to Equity Ratio 2018-2022 | RUBY
Current and historical debt to equity ratio values for Rubius Therapeutics, Inc. (RUBY) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Rubius Therapeutics, Inc. debt/equity for the three months ending December 31, 2022 was .
Debt/Equity Ratio Historical Data |
Date |
Long Term Debt |
Shareholder's Equity |
Debt to Equity Ratio |
2022-12-31 |
$0.01B |
$0.02B |
0.53 |
2022-09-30 |
$0.13B |
$0.04B |
3.67 |
2022-06-30 |
$0.13B |
$0.10B |
1.40 |
2022-03-31 |
$0.13B |
$0.14B |
0.98 |
2021-12-31 |
$0.14B |
$0.18B |
0.78 |
2021-09-30 |
$0.14B |
$0.22B |
0.61 |
2021-06-30 |
$0.13B |
$0.26B |
0.50 |
2021-03-31 |
$0.13B |
$0.30B |
0.43 |
2020-12-31 |
$0.14B |
$0.14B |
0.96 |
2020-09-30 |
$0.14B |
$0.17B |
0.80 |
2020-06-30 |
$0.14B |
$0.21B |
0.68 |
2020-03-31 |
$0.11B |
$0.24B |
0.48 |
2019-12-31 |
$0.12B |
$0.27B |
0.44 |
2019-09-30 |
$0.13B |
$0.31B |
0.41 |
2019-06-30 |
$0.09B |
$0.34B |
0.28 |
2019-03-31 |
$0.07B |
$0.37B |
0.19 |
2018-12-31 |
$0.09B |
$0.39B |
0.22 |
2018-09-30 |
$0.04B |
$0.41B |
0.10 |
2018-06-30 |
$0.04B |
$0.17B |
0.22 |
2018-03-31 |
$0.00B |
|
0.00 |
2017-09-30 |
$0.00B |
|
0.00 |
2017-06-30 |
$0.00B |
|
0.00 |